Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Fine Foods & Pharmaceuticals N.T.M. S.p.A. (FF.MI)
Verdellino, BG, IT
Fine Foods & Pharmaceuticals N.T.M. S.p.A. functions as a contract development and manufacturing organization (CDMO), specializing in the creation of various oral solid forms for the pharmaceutical and nutraceutical sectors. Its pharmaceutical offerings include items such as powders, granules, capsules, standard and film-coated tablets, effervescent granules, and hard gelatine capsules. For the nutraceutical market, the company produces soluble, effervescent, and chewable tablets, fast-melting/sublingual tablets, film-coated tablets, and hard gelatine capsules, alongside soluble and effervescent powders and granules. These nutraceutical products are designed to support a wide range of health needs, encompassing areas like probiotics, multivitamins and minerals, immune system function, sleep and relaxation, gastrointestinal and circulatory health, osteoarticular and urinary systems, women's health, beauty, healthy aging, and mental wellbeing. In addition to its core CDMO services, the company also manufactures and sells a diverse array of cosmetic products, covering hair care, skin care, liquid personal hygiene items, oral hygiene products, deodorants, alcohol-based perfumery, bath and shower gels, shampoos and conditioners, shaping waxes, mouthwashes, creams, gels, and toothpastes. Furthermore, they supply medical surgical aids and devices, various antiseptics for intact skin, hand sanitizers, pre-injection solutions, hydroalcoholic surface cleaners, and iodine. Their product line also extends to orthodontic cleaning tablets, disinfectants, and decongestant nasal sprays. Established in 1984, the company is headquartered in Verdellino, Italy.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -0.72% | -3.29% | -4.20% | -23.18% | -11.80% | -13.47% | +8.16% | +10.34% | -39.56% | -17.80% | +1,162.09% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 2 | 0 |
| Buy | 3 | -1 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Packaged Foods: +4.4%+3.4% Q1'26: -7.2% (vs Q1'25)
-
EPS growth Packaged Foods: +14.6%+25.0% ★ Q1'26: -76.5% (vs Q1'25)
-
FCF margin FCF growth · Packaged Foods: +15.9%+3.3% Q1'26: -10.3% (vs Q1'25)
-
EBIT margin Packaged Foods: +7.9%+6.5% Q1'26: +3.7% (vs Q1'25)
-
ROIC Packaged Foods: +7.0%+6.7% Q1'26: +2.7% (vs Q1'25)
-
Share dilution Packaged Foods: +0.0%+0.0% Q1'26: -9.8% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Packaged Foods: 0.19×2.52× Q1'26: 3.09× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 4 Rev. Ana. 3 EPS Ana. |
Dec 2027 4 Rev. Ana. 3 EPS Ana. |
Dec 2028 3 Rev. Ana. 3 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
139.39M
est: 129.60M (+7.6%)
|
159.66M
est: 162.54M (-1.8%)
|
173.04M
est: 176.80M (-2.1%)
|
194.42M
est: 195.00M (-0.3%)
|
206.85M
est: 208.00M (-0.6%)
|
251.81M
est: 247.19M (+1.9%)
|
243.75M
est: 244.60M (-0.3%)
|
252.06M
est: 252.36M (-0.1%)
|
270.41M
255.35M – 285.85M
+7.2% YoY
|
295.14M
276.35M – 311.09M
+9.1% YoY
|
310.57M
304.30M – 316.83M
+5.2% YoY
|
| EBITDA |
18.66M
est: 11.36M (+64.3%)
|
10.30M
est: 14.24M (-27.7%)
|
28.81M
est: 15.49M (+85.9%)
|
9.86M
est: 17.09M (-42.3%)
|
3.64M
est: 18.23M (-80.0%)
|
19.29M
est: 64.18M (-69.9%)
|
30.90M
est: 63.51M (-51.3%)
|
34.43M
est: 65.53M (-47.5%)
|
70.21M
66.30M – 74.22M
+7.2% YoY
|
76.63M
71.76M – 80.77M
+9.1% YoY
|
80.64M
79.01M – 82.27M
+5.2% YoY
|
| EBIT |
10.95M
est: 2.55M (+328.8%)
|
937.6K
est: 3.20M (-70.7%)
|
17.54M
est: 3.48M (+403.4%)
|
-3.54M
est: 3.84M (-192.1%)
|
-11.81M
est: 4.10M (-388.1%)
|
3.16M
est: 47.33M (-93.3%)
|
15.13M
est: 46.83M (-67.7%)
|
16.42M
est: 48.32M (-66.0%)
|
51.78M
48.89M – 54.73M
+7.2% YoY
|
56.51M
52.91M – 59.56M
+9.1% YoY
|
59.46M
58.26M – 60.66M
+5.2% YoY
|
| Net Income |
8.69M
est: 8.18M (+6.2%)
|
-2.79M
est: 8.62M (-132.4%)
|
13.36M
est: 10.99M (+21.6%)
|
-1.43M
est: 11.48M (-112.4%)
|
-9.50M
est: -12.52M (+24.1%)
|
-3.52M
est: 2.61M (-234.9%)
|
8.16M
est: 9.37M (-13.0%)
|
10.10M
est: 12.00M (-15.8%)
|
14.47M
12.97M – 18.27M
+20.6% YoY
|
17.01M
16.42M – 20.55M
+17.5% YoY
|
20.62M
19.97M – 22.11M
+21.2% YoY
|
| SGA |
10.72M
est: 5.50M (+94.9%)
|
1.41M
est: 6.89M (-79.5%)
|
1.52M
est: 7.50M (-79.7%)
|
7.34M
est: 8.27M (-11.2%)
|
24.70M
est: 8.82M (+180.0%)
|
6.10M
est: 10.35M (-41.1%)
|
5.34M
est: 10.24M (-47.9%)
|
1.51M
est: 10.56M (-85.7%)
|
11.32M
10.69M – 11.96M
+7.2% YoY
|
12.35M
11.57M – 13.02M
+9.1% YoY
|
13.00M
12.74M – 13.26M
+5.2% YoY
|
| EPS |
0.85
est: 0.32 (+165.6%)
|
-0.12
est: 0.34 (-135.6%)
|
0.58
est: 0.43 (+34.9%)
|
-0.06
est: 0.45 (-113.3%)
|
-0.37
est: -0.49 (+24.5%)
|
-0.14
est: 0.11 (-231.3%)
|
0.32
est: 0.37 (-12.9%)
|
0.40
est: 0.48 (-16.8%)
|
0.60
0.51 – 0.71
+25.4% YoY
|
0.71
0.64 – 0.80
+17.9% YoY
|
0.82
0.78 – 0.86
+15.0% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-08 | B | 3/5 | 1/5 | 3/5 | 4/5 | 2/5 | 3/5 | 4/5 |
| 2026-05-07 | B | 3/5 | 1/5 | 3/5 | 4/5 | 2/5 | 3/5 | 4/5 |
| 2026-05-06 | B | 3/5 | 1/5 | 3/5 | 4/5 | 2/5 | 3/5 | 4/5 |
| 2026-05-05 | B | 3/5 | 1/5 | 3/5 | 4/5 | 2/5 | 3/5 | 4/5 |
| 2026-05-04 | B | 3/5 | 1/5 | 3/5 | 4/5 | 2/5 | 3/5 | 4/5 |
| 2026-04-30 | B | 3/5 | 1/5 | 3/5 | 4/5 | 2/5 | 3/5 | 4/5 |
| 2026-04-29 | B | 3/5 | 1/5 | 3/5 | 4/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-28 | B | 3/5 | 1/5 | 3/5 | 4/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-27 | B | 3/5 | 1/5 | 3/5 | 4/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-24 | B | 3/5 | 1/5 | 3/5 | 4/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-23 | B | 3/5 | 1/5 | 3/5 | 4/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-22 | B | 3/5 | 1/5 | 3/5 | 4/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-21 | B | 3/5 | 1/5 | 3/5 | 4/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-20 | B | 3/5 | 1/5 | 3/5 | 4/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-17 | B | 3/5 | 1/5 | 3/5 | 4/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-16 | B | 3/5 | 1/5 | 3/5 | 4/5 | 1/5 | 3/5 | 4/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | Avantis International Small Cap Value ETF AVDV | 0.00% | 641.03 | 0.36% |
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Marco Francesco Eigenmann | President, Chief Executive Officer & Director | — | male |
| Pietro Oriani | MD & Director | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for FF.MI
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
